Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
Recruiting · NCT06739330 · Observational (researchers observe without assigning treatment) · Lead sponsor: Tanta University
View the official record on ClinicalTrials.gov →Interventions studied
Fibroscan
What this trial is about
This study aims to evaluate the prevalence of thyroid dysfunction and its association with metabolic dysfunction-associated fatty liver disease.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥ 18 years.
- Both sexes.
- Patients with metabolic dysfunction-associated fatty liver disease (MAFLD).
Exclusion criteria
- History of thyroid disease or treatment (e.g., thyroid nodules, thyroid cancer, hypothyroidism, and hyperthyroidism).
- Patients with alcoholic liver disease take more than 40g of alcohol (or four units) per day.
- Viral hepatitis.
- Pregnant women.
Where it is running
1 location listed.
- Tanta University - Tanta, El-Gharbia, Egypt